Market Size of Capecitabine Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Capecitabine Market Analysis
The Capecitabine market studied was anticipated to grow with a CAGR of 5.5% during the forecast period owing to the rising demand for target drug therapy to decrease the possible side effects without affecting normal cells. Increased demand for the capecitabine can be attributed to their antimetabolite activity that specifically works by interfering with DNA synthesis minimizing the severe adverse effects. Also, the growing global burden of patients diagnosed with cancer and tumors is likely to drive the market. As per the World Health Organization report, cancer is a leading cause of death worldwide and estimated that nearly 9.6 million deaths in 2018. Also, it is estimated that 627,000 women died from breast cancer accounting for about 15% of all cancer deaths among women across the globe. Also, a steep rise in healthcare expenditure, ongoing R&D activities in cancer treatment are likely to provide new opportunities for the market. Furthermore, growing awareness programs by governments and private organizations such as Cancer Care, Cancer Research UK, and Cancer Suraksha Scheme are anticipated to propel the global capecitabine market growth over the course of the period.
